These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 24152740)
1. Biologic therapy for atopic asthma and beyond. Caruso M; Crisafulli E; Lizzio R; Polosa R Curr Opin Allergy Clin Immunol; 2013 Dec; 13(6):677-85. PubMed ID: 24152740 [TBL] [Abstract][Full Text] [Related]
2. Stratified approaches to the treatment of asthma. Holgate ST Br J Clin Pharmacol; 2013 Aug; 76(2):277-91. PubMed ID: 23163316 [TBL] [Abstract][Full Text] [Related]
3. Biologic therapy in asthma: entering the new age of personalized medicine. Fajt ML; Wenzel SE J Asthma; 2014 Sep; 51(7):669-76. PubMed ID: 24712500 [TBL] [Abstract][Full Text] [Related]
4. Immunomodulatory and biologic therapies for severe refractory asthma. Polosa R; Morjaria J Respir Med; 2008 Nov; 102(11):1499-510. PubMed ID: 19012848 [TBL] [Abstract][Full Text] [Related]
5. Biologic targeted therapy in allergic asthma. Bice JB; Leechawengwongs E; Montanaro A Ann Allergy Asthma Immunol; 2014 Feb; 112(2):108-15. PubMed ID: 24468249 [TBL] [Abstract][Full Text] [Related]
6. Biologic Therapy and Novel Molecular Targets of Severe Asthma. Pepper AN; Renz H; Casale TB; Garn H J Allergy Clin Immunol Pract; 2017; 5(4):909-916. PubMed ID: 28689841 [TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies for chronic refractory asthma and pipeline developments. Polosa R; Casale T Drug Discov Today; 2012 Jun; 17(11-12):591-9. PubMed ID: 22306350 [TBL] [Abstract][Full Text] [Related]
9. An update on emerging drugs for asthma. Walsh GM Expert Opin Emerg Drugs; 2012 Mar; 17(1):37-42. PubMed ID: 22292562 [TBL] [Abstract][Full Text] [Related]
10. Molecular phenotyping and biomarker development: are we on our way towards targeted therapy for severe asthma? De Ferrari L; Chiappori A; Bagnasco D; Riccio AM; Passalacqua G; Canonica GW Expert Rev Respir Med; 2016; 10(1):29-38. PubMed ID: 26566089 [TBL] [Abstract][Full Text] [Related]
11. Biologic therapy in the management of asthma. McCracken JL; Tripple JW; Calhoun WJ Curr Opin Allergy Clin Immunol; 2016 Aug; 16(4):375-82. PubMed ID: 27362324 [TBL] [Abstract][Full Text] [Related]
12. IL-13 in asthma and allergic disease: asthma phenotypes and targeted therapies. Ingram JL; Kraft M J Allergy Clin Immunol; 2012 Oct; 130(4):829-42; quiz 843-4. PubMed ID: 22951057 [TBL] [Abstract][Full Text] [Related]
13. Targeted biologic therapy for asthma. Hynes G; Pavord ID Br Med Bull; 2020 May; 133(1):16-35. PubMed ID: 32318701 [TBL] [Abstract][Full Text] [Related]
14. Asthma Phenotypes as a Guide for Current and Future Biologic Therapies. Hamilton D; Lehman H Clin Rev Allergy Immunol; 2020 Oct; 59(2):160-174. PubMed ID: 31359247 [TBL] [Abstract][Full Text] [Related]
16. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
17. [Imbalanced T cell-specific transcription factors T-bet and GATA-3 contributes to type 2 T helper cell polarization in asthmatic patients]. Liu CT; Wang G; Luo FM; Wang ZL; Liu R; Wang CL Zhonghua Jie He He Hu Xi Za Zhi; 2004 Jun; 27(6):398-402. PubMed ID: 15256090 [TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibodies for the treatment of asthma. Catley MC; Coote J; Bari M; Tomlinson KL Pharmacol Ther; 2011 Dec; 132(3):333-51. PubMed ID: 21944943 [TBL] [Abstract][Full Text] [Related]
19. Th2 cytokine antagonists: potential treatments for severe asthma. Hansbro PM; Scott GV; Essilfie AT; Kim RY; Starkey MR; Nguyen DH; Allen PD; Kaiko GE; Yang M; Horvat JC; Foster PS Expert Opin Investig Drugs; 2013 Jan; 22(1):49-69. PubMed ID: 23126660 [TBL] [Abstract][Full Text] [Related]